Neurogene Inc. Unrecognized Tax Benefits
Neurogene Inc. (NGNE) had Unrecognized Tax Benefits of $4.82 million as of 2025-12-31, per its 10-K filed 2026-03-24.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefits · last filed 2026-03-24
- 2025-12-31: Unrecognized Tax Benefits $4.82M.
- 2024-12-31: Unrecognized Tax Benefits $3.36M.
- 2023-12-31: Unrecognized Tax Benefits $2.61M.
- 2022-12-31: Unrecognized Tax Benefits $1.11M.
| Period end | Unrecognized Tax Benefits |
|---|---|
| 2025-12-31 | $4.82M 10-K · filed 2026-03-24 |
| 2024-12-31 | $3.36M 10-K · filed 2026-03-24 |
| 2023-12-31 | $2.61M 10-K · filed 2026-03-24 |
| 2022-12-31 | $1.11M 10-K · filed 2025-03-24 |
| 2021-12-31 | $632.00K 10-K · filed 2024-03-18 |
| 2019-12-31 | $0.00 10-K · filed 2020-03-12 |
| 2018-12-31 | $0.00 10-K · filed 2019-03-07 |
| 2017-12-31 | $0.00 10-K · filed 2018-03-12 |
| 2016-12-31 | $0.00 10-K · filed 2017-03-09 |
| 2015-12-31 | $0.00 10-K · filed 2016-03-14 |
| 2014-12-31 | $0.00 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |